Market News & Trends
Global Pain Market Presents Significant Opportunities for Novel Mechanisms & Modalities
There is a lack of diversity within the current pain market, with non-steroidal anti-inflammatory drugs (NSAIDs) and opioids dominating the market. With 98% of currently…
SGS Receives Regulatory Approval to Restart Human ¹⁴C ADME Trials
SGS recently announced it has received formal approval from the Belgian Federal Agency for Nuclear Control (FANC) to resume human ADME (Adsorption, Distribution, Metabolism and…
Lonza Strengthens Advanced Synthesis Capabilities to Lead Bioconjugates Innovation & Development
Lonza recently announced that it has strengthened its Advanced Synthesis offering to increase phase-appropriate support for the discovery and development of antibody-drug conjugates (ADCs) and…
Proveris Laboratories Launches Redesigned Website Focused on Analytical Clarity in OINDP Development
Proveris Laboratories recently announced the launch of a redesigned website centered on its analytical and regulatory expertise in orally inhaled and nasal drug product (OINDP)…
RoukenBio & AVS Bio Announce Strategic Partnership to Integrate Design-Focused Antibody Discovery & OptimiZation With Mechanism-Driven Functional Characterization
RoukenBio and AVS Bio recently announced a strategic partnership that integrates AVS Bio’s comprehensive antibody discovery and development services with RoukenBio’s expertise in mechanism-driven functional…
Thermo Fisher Scientific Introduces Sequential Protein/DNA/RNA Extraction Kit That Enables Genomic, Transcriptomic & Proteomic Analysis from a Single Sample to Support Cancer & Disease Research
Thermo Fisher Scientific introduces the Thermo Scientific Sequential Protein/DNA/RNA Extraction Kit, a sample preparation solution designed to enable the sequential extraction of protein, DNA and…
Cellares & University of Wisconsin School of Medicine & Public Health Expand Partnership to Clinical Manufacturing of CRISPR-Edited CAR-T for Solid Tumors
Cellares and the University of Wisconsin (UW) School of Medicine and Public Health recently announced an expansion of their partnership to support clinical production and…
Affibody’s Licensee Announces Positive Data for Phase 1 Study Demonstrating Complete & Sustained Inhibition of Terminal Complement
Affibody’s licensee Rallybio Corporation (Rallybio) has announced positive results from its Phase 1 confirmatory pharmacokinetic/pharmacodynamic (PK/PD) clinical study evaluating RLYB116, an innovative, once-weekly, small volume,…
Axplora Announces Multi-Million Investment to Expand Lyophilization at Le Mans & Appoints New Head of Site
Axplora recently announced a multi-million-euro investment to expand lyophilization capabilities at its Le Mans site, strengthening its ability to deliver reliable, efficient and fast ADC…
Korsana Biosciences Emerges From Stealth With $175 Millon in Funding to Advance Potential Best-in-Class Therapeutics for Neurodegenerative Diseases
Korsana Biosciences, Inc. recently announced its emergence from stealth, with backing from a leading syndicate of healthcare investors. The Company was founded in 2024 with…
Axol Bioscience Acquires Ophthalmology Business From Newcells Biotech
Axol Bioscience Ltd. recently announced it has acquired the ophthalmology business of Newcells Biotech, a leading drug discovery partner specializing in the development of in…
Evogene & Queensland University of Technology Announce a Collaboration to Advance AI-Driven Cancer Therapeutics
Evogene Ltd. recently announced a collaboration with the pioneering research group of Dr. Mark Adams, a leading cancer genomics expert in the School of Biomedical…
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics & $200 Million Concurrent Private Placement
Sensei Biotherapeutics, Inc. recently announced it has acquired Faeth Therapeutics Inc., a clinical-stage biotechnology company developing multi-node therapies that target tumor metabolism and signaling. The…
Nuclera & leadXpro Partner to Accelerate Structure-Based Drug Design for Complex Membrane Proteins
Nuclera and leadXpro recently announced a scientific partnership. The collaboration brings together eProtein Discovery’s rapid multiplex membrane protein screening with leadXpro’s AI/ML-driven construct design and…
Deciphera Pharmaceuticals Announces US FDA Acceptance for Filing of NDA for Tirabrutinib in Patients With Relapsed or Refractory PCNSL
Deciphera Pharmaceuticals recently announced the US FDA has accepted for filing the New Drug Application (NDA) under the accelerated approval pathway for tirabrutinib, a highly…
Capricorn Scientific Expands European Infrastructure to Drive Scalable Biotech & Pharma Growth
Capricorn Scientific is expanding its European footprint with a new 4,000 m² logistics and infrastructure hub in Ebsdorfergrund, Germany - designed to strengthen supply security,…
Cyrano Therapeutics Announces Positive Topline Results of a Proprietary & Potential First-to-Market Regenerative Therapy for Persistent Smell Loss
Cyrano Therapeutics, Inc. recently announced positive topline results from its Phase 2 FLAVOR trial of CYR-064, an innovative, intranasal soft-mist spray for the treatment of persistent…
Annovis Secures DSMB Approval to Advance Pivotal Phase 3 Trial of Buntanetap in Alzheimer’s Disease
Annovis Bio, Inc. recently announced an independent Data and Safety Monitoring Board (DSMB) has issued a positive recommendation regarding the safety of buntanetap at 6…
Rottendorf Pharma & Corealis Pharma Offer Seamless OSD Development & Manufacturing
Rottendorf Pharma and Corealis Pharma have expanded their service offering through a strategic partnership. The collaboration offers pharmaceutical and biotech companies a strategic transatlantic alliance…
Sirio Pharma to Introduce First-in-Market Lutein Soft Chew for Eye Health
Sirio Pharma has collaborated with prominent science-backed ingredient provider OmniActive Health Technologies (OmniActive) to launch a first-in-market soft chew lutein supplement. Featuring OmniActive’s award-winning Lutemax…
